Literature DB >> 15542667

SYNCRIP, a member of the heterogeneous nuclear ribonucleoprotein family, is involved in mouse hepatitis virus RNA synthesis.

Keum S Choi1, Akihiro Mizutani, Michael M C Lai.   

Abstract

Several cellular proteins, including several heterogeneous nuclear ribonucleoproteins (hnRNPs), have been shown to function as regulatory factors for mouse hepatitis virus (MHV) RNA synthesis as a result of their binding to the 5' and 3' untranslated regions (UTRs) of the viral RNA. Here, we identified another cellular protein, p70, which has been shown by UV cross-linking to bind both the positive- and negative-strand UTRs of MHV RNA specifically. We purified p70 with a a one-step RNA affinity purification procedure with the biotin-labeled 5'-UTR. Matrix-assisted laser desorption ionization (MALDI)-mass spectrometry identified it as synaptotagmin-binding cytoplasmic RNA-interacting protein (SYNCRIP). SYNCRIP is a member of the hnRNP family and localizes largely in the cytoplasm. The p70 was cross-linked to the MHV positive- or negative-strand UTR in vitro and in vivo. The bacterially expressed SYNCRIP was also able to bind to the 5'-UTR of both strands. The SYNCRIP-binding site was mapped to the leader sequence of the 5'-UTR, requiring the UCUAA repeat sequence. To investigate the functional significance of SYNCRIP in MHV replication, we expressed a full-length or a C-terminally truncated form of SYNCRIP in mammalian cells expressing the MHV receptor. The overexpression of either form of SYNCRIP inhibited syncytium formation induced by MHV infection. Furthermore, downregulation of the endogenous SYNCRIP with a specific short interfering RNA delayed MHV RNA synthesis; in contrast, overexpression or downregulation of SYNCRIP did not affect MHV translation. These results suggest that SYNCRIP may be directly involved in MHV RNA replication as a positive regulator. This study identified an additional cellular hnRNP as an MHV RNA-binding protein potentially involved in viral RNA synthesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542667      PMCID: PMC525026          DOI: 10.1128/JVI.78.23.13153-13162.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  SYNCRIP, a cytoplasmic counterpart of heterogeneous nuclear ribonucleoprotein R, interacts with ubiquitous synaptotagmin isoforms.

Authors:  A Mizutani; M Fukuda; K Ibata; Y Shiraishi; K Mikoshiba
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

2.  Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture.

Authors:  N Hirano; K Fujiwara; S Hino; M Matumoto
Journal:  Arch Gesamte Virusforsch       Date:  1974

3.  Interactions between the cytoplasmic proteins and the intergenic (promoter) sequence of mouse hepatitis virus RNA: correlation with the amounts of subgenomic mRNA transcribed.

Authors:  X Zhang; M M Lai
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

4.  Three different cellular proteins bind to complementary sites on the 5'-end-positive and 3'-end-negative strands of mouse hepatitis virus RNA.

Authors:  T Furuya; M M Lai
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

5.  Specific interaction between coronavirus leader RNA and nucleocapsid protein.

Authors:  S A Stohlman; R S Baric; G N Nelson; L H Soe; L M Welter; R J Deans
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

6.  A system for study of coronavirus mRNA synthesis: a regulated, expressed subgenomic defective interfering RNA results from intergenic site insertion.

Authors:  S Makino; M Joo; J K Makino
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

7.  La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate.

Authors:  K Meerovitch; Y V Svitkin; H S Lee; F Lejbkowicz; D J Kenan; E K Chan; V I Agol; J D Keene; N Sonenberg
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

8.  Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus.

Authors:  J O Fleming; S A Stohlman; R C Harmon; M M Lai; J A Frelinger; L P Weiner
Journal:  Virology       Date:  1983-12       Impact factor: 3.616

9.  Sequence motifs involved in the regulation of discontinuous coronavirus subgenomic RNA synthesis.

Authors:  Sonia Zúñiga; Isabel Sola; Sara Alonso; Luis Enjuanes
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

10.  Primary structure and translation of a defective interfering RNA of murine coronavirus.

Authors:  S Makino; C K Shieh; L H Soe; S C Baker; M M Lai
Journal:  Virology       Date:  1988-10       Impact factor: 3.616

View more
  30 in total

1.  Poly(C)-binding protein 2 interacts with sequences required for viral replication in the hepatitis C virus (HCV) 5' untranslated region and directs HCV RNA replication through circularizing the viral genome.

Authors:  Linya Wang; King-Song Jeng; Michael M C Lai
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

Review 2.  The molecular biology of coronaviruses.

Authors:  Paul S Masters
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

3.  The transcription-dependent dissociation of P-TEFb-HEXIM1-7SK RNA relies upon formation of hnRNP-7SK RNA complexes.

Authors:  Charlotte Barrandon; François Bonnet; Van Trung Nguyen; Valérie Labas; Olivier Bensaude
Journal:  Mol Cell Biol       Date:  2007-08-20       Impact factor: 4.272

4.  Mechanistic consequences of hnRNP C binding to both RNA termini of poliovirus negative-strand RNA intermediates.

Authors:  Kenneth J Ertel; Jo Ellen Brunner; Bert L Semler
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

5.  The acidic domain is a unique structural feature of the splicing factor SYNCRIP.

Authors:  Christine Beuck; James R Williamson; Kurt Wüthrich; Pedro Serrano
Journal:  Protein Sci       Date:  2016-05-17       Impact factor: 6.725

6.  The polypyrimidine tract-binding protein affects coronavirus RNA accumulation levels and relocalizes viral RNAs to novel cytoplasmic domains different from replication-transcription sites.

Authors:  Isabel Sola; Carmen Galán; Pedro A Mateos-Gómez; Lorena Palacio; Sonia Zúñiga; Jazmina L Cruz; Fernando Almazán; Luis Enjuanes
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

7.  Suppression of coronavirus replication by inhibition of the MEK signaling pathway.

Authors:  Yingyun Cai; Yin Liu; Xuming Zhang
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

Review 8.  Continuous and Discontinuous RNA Synthesis in Coronaviruses.

Authors:  Isabel Sola; Fernando Almazán; Sonia Zúñiga; Luis Enjuanes
Journal:  Annu Rev Virol       Date:  2015-11       Impact factor: 10.431

9.  Intracellular restriction of a productive noncytopathic coronavirus infection.

Authors:  Olga Slobodskaya; Alexander Laarman; Willy J M Spaan
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

10.  The proteins of intra-nuclear bodies: a data-driven analysis of sequence, interaction and expression.

Authors:  Nurul Mohamad; Mikael Bodén
Journal:  BMC Syst Biol       Date:  2010-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.